{
	"fund": "Fairmount Funds Management LLC",
	"id": "US13F1802528",
	"url": "https://titelia.com/en/funds/US13F1802528",
	"manager": "",
	"filing": "13f",
	"currency": "USD",
	"net_assets": null,
	"as_of": "2026-03-31",
	"page": {
		"total": 11,
		"limit": 1000,
		"offset": 0,
		"more": false,
		"next": null,
		"previous": null
	},
	"holdings": [
		{
			"isin": "US36322Q2066",
			"company": "DAMORA THERAPEUTICS INC",
			"company_url": "https://titelia.com/en/stocks/damora-therapeutics-inc-US36322Q2066",
			"country": "US",
			"shares": 8713000,
			"value": 225666700,
			"currency": "USD",
			"weight": 0,
			"as_of": "2026-03-31"
		},
		{
			"isin": "US2528281080",
			"company": "Dianthus Therapeutics Inc",
			"company_url": "https://titelia.com/en/stocks/dianthus-therapeutics-inc-US2528281080",
			"country": "US",
			"shares": 2537191,
			"value": 212921069,
			"currency": "USD",
			"weight": 0,
			"as_of": "2026-03-31"
		},
		{
			"isin": "US19240Q2012",
			"company": "Cogent Biosciences Inc",
			"company_url": "https://titelia.com/en/stocks/cogent-biosciences-inc-US19240Q2012",
			"country": "US",
			"shares": 5503418,
			"value": 211826559,
			"currency": "USD",
			"weight": 0,
			"as_of": "2026-03-31"
		},
		{
			"isin": "US00773J2024",
			"company": "Spyre Therapeutics Inc",
			"company_url": "https://titelia.com/en/stocks/spyre-therapeutics-inc-US00773J2024",
			"country": "US",
			"shares": 4018101,
			"value": 202673014,
			"currency": "USD",
			"weight": 0,
			"as_of": "2026-03-31"
		},
		{
			"isin": "US6876041087",
			"company": "Oruka Therapeutics Inc",
			"company_url": "https://titelia.com/en/stocks/oruka-therapeutics-inc-US6876041087",
			"country": "US",
			"shares": 3705262,
			"value": 181743101,
			"currency": "USD",
			"weight": 0,
			"as_of": "2026-03-31"
		},
		{
			"isin": "US92790C1045",
			"company": "Viridian Therapeutics Inc",
			"company_url": "https://titelia.com/en/stocks/viridian-therapeutics-inc-US92790C1045",
			"country": "US",
			"shares": 3914458,
			"value": 76566798,
			"currency": "USD",
			"weight": 0,
			"as_of": "2026-03-31"
		},
		{
			"isin": "US29337E1029",
			"company": "Enliven Therapeutics Inc",
			"company_url": "https://titelia.com/en/stocks/enliven-therapeutics-inc-US29337E1029",
			"country": "US",
			"shares": 1855644,
			"value": 72741245,
			"currency": "USD",
			"weight": 0,
			"as_of": "2026-03-31"
		},
		{
			"isin": "US0080642061",
			"company": "JADE BIOSCIENCES INC",
			"company_url": "https://titelia.com/en/stocks/jade-biosciences-inc-US0080642061",
			"country": "US",
			"shares": 4553494,
			"value": 63976591,
			"currency": "USD",
			"weight": 0,
			"as_of": "2026-03-31"
		},
		{
			"isin": "US98937L1052",
			"company": "ZENAS BIOPHARMA INC",
			"company_url": "https://titelia.com/en/stocks/zenas-biopharma-inc-US98937L1052",
			"country": "US",
			"shares": 2359025,
			"value": 46118939,
			"currency": "USD",
			"weight": 0,
			"as_of": "2026-03-31"
		},
		{
			"isin": "US03770N1019",
			"company": "Apogee Therapeutics Inc",
			"company_url": "https://titelia.com/en/stocks/apogee-therapeutics-inc-US03770N1019",
			"country": "US",
			"shares": 298647,
			"value": 25137118,
			"currency": "USD",
			"weight": 0,
			"as_of": "2026-03-31"
		},
		{
			"isin": "US45719W2052",
			"company": "Inhibikase Therapeutics Inc",
			"company_url": "https://titelia.com/en/stocks/inhibikase-therapeutics-inc-US45719W2052",
			"country": "US",
			"shares": 8625000,
			"value": 14490000,
			"currency": "USD",
			"weight": 0,
			"as_of": "2026-03-31"
		}
	],
	"source": "Public filings of the fund regulators, republished by titelia",
	"served_by": {
		"name": "titelia",
		"url": "https://titelia.com/en/api"
	},
	"terms": "https://titelia.com/en/mentions",
	"documentation": "https://titelia.com/en/api"
}